|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
METHODS IN CELL PHYSIOLOGY
1Department of Bioengineering, The Pennsylvania State University, University Park, Pennsylvania; and 2National Microgravity Laboratory and Center for Biomechanics and Bioengineering, Institute of Mechanics, Chinese Academy of Sciences, Beijing, People's Republic of China
Submitted 12 June 2007 ; accepted in final form 13 January 2008
| ABSTRACT |
|---|
|
|
|---|
heterotypic cell aggregation; adhesion molecule; leukocyte; tumor cell; reverse rate; binding affinity; probabilistic model; polymorphonuclear neutrophils; intercellular adhesion molecule-1
(27). Inhibition of ICAM-1 expression on melanoma cells reduces the metastatic ability of the melanoma cells (27), indicating an important role of ICAM-1 in metastasis. β2-Integrin is a heterodimeric molecule that consists of
- and β-subunits with an extracellular domain, a transmembrane domain, and a cytoplasmic tail. β2-Integrin on PMNs has been shown to be upregulated on stimulation of chemoattractant, which is essential for PMNs to form firm adhesion to the EC and subsequent migration to the surrounding tissue in response to inflammation (2, 40). Cellular aggregation kinetics has been extensively investigated in the past decades. For example, the heterotypic aggregation between transfected cells (or beads) expressing ICAM-1 and PMNs in a shear flow has been quantified in terms of cell adhesion or capture efficiency, suggesting that the adhesion of PMNs to ICAM-1-expressing cells is a cooperative and sequential process of LFA-1-dependent initial endothelial capture of PMNs followed by Mac-1-mediated stabilization (12, 28) and that the aggregation is upregulated by chemotactic stimulation with a high-affinity conformation of active CD18 (25). Such shear-induced aggregations have also been observed experimentally from the interactions between PMNs and colon carcinomas expressing ICAM-1 and sialylated molecules (15, 16); the doublet formation and breakage of red cells and of latex spheres crossed-linked by antigen-antibody bonds (17, 44, 45); the homotypic aggregation of PMNs mediated by L-selectin and β2-integrin adhesion receptors (43); the heterotypic aggregation of PMNs and cells transfected with ICAM-1 (12, 26, 28), E- or L-selectin (26); or PMNs and platelets or beads coated with P-selectin glycoprotein ligand 1 (PSGL-1; 26) or ICAM-1 (33). All of these observations provide an increasing recognition in cellular aggregation kinetics, which is crucial to many biological processes such as tumor metastasis, inflammatory cascade, and thrombus formation. However, cellular aggregation kinetics has rarely been correlated to the intrinsic molecular kinetics of underlying interacting molecules, especially in tumor cell adhesion.
To mediate aggregations between melanoma cells and PMNs, both ICAM-1 and β2-integrin molecules must be anchored onto two apposing surfaces, which is called two-dimensional (2D) interaction. 2D kinetics of β2-integrin and ICAM-1 bindings governs how likely or strongly they bind and how long they remain bound, which consequently determine the dynamic aggregations between cells. This is different from three-dimensional (3D) binding in which at least one of the receptors and ligands is in a fluid phase. In previous studies, a deterministic kinetic model upon bulk chemistry, combined with two-body collision theory (38), was proposed to predict the forward- and reverse-rates of β2-integrin and L-selectin for PMN aggregation (42) and of GPIIb/IIIa integrin for platelet aggregation (41). A similar deterministic model was also used to estimate the cellular reverse rate of β2-integrin and L-selectin for PMN aggregation (29). To further understand the molecular mechanism that determines the cellular aggregation kinetics, a 2D probabilistic kinetic model would be required since the 2D receptor-ligand binding is no longer a deterministic but a stochastic process (6, 13, 47). In addition, the 2D kinetics should be coupled to the mechanics of receptor-ligand binding since the external forces exerted by shear flow regulate the bond formation and dissociation (4).
We have previously developed a probabilistic kinetic model to predict shear-induced doublet formations and breakages of red cells and of latex spheres crossed-linked by antigen-antibody bonds and to estimate the intrinsic forward- and reverse-rates by fitting the data with the model (24). Here we extended that model to predict aggregations between chemotactically stimulated PMNs and melanoma cells mediated by β2-integrin and ICAM-1 bindings. A cone-plate viscometer was used to provide a uniform shear-flow field, and flow cytometry was employed to measure the cell aggregation. The effects of hydrodynamic shear stresses, shear rates, and β2-integrin and ICAM-1 expressions were determined experimentally. Best-fitting the data with the proposed model predicted the intrinsic kinetic rates and binding affinity of interacting β2-integrin-ICAM-1 pairs between PMNs and melanoma cells.
| MATERIALS AND METHODS |
|---|
|
|
|---|
; Sigma) for 24 h. After stimulation, WM9 cells were spun down and resuspended in fresh media for use. Following the Pennsylvania State University Institutional Review Board approved protocols (no. 19311), fresh human blood samples were collected from healthy donors by venipuncture. PMNs were isolated using a Histopaque (Sigma, St. Louis, MO) density gradient according to the manufacturer's instruction and were kept at 4°C in Dulbecco's PBS containing 0.1% human serum albumin for up to 4 h before use. To upregulate the expression of β2-integrin, PMNs were incubated with 1 µM formyl-methionyl-leucyl-phenylalanine (fMLP; Sigma) for 2 min. For blocking experiments, fMLP-stimulated PMNs were pretreated for 30 min at 4°C with anti-CD11a and anti-CD11b mAbs (Invitrogen) at 5 µg/106 cells.
Determination of aggregation.
To measure the interactions between PMNs and WM9 cells, heterotypic aggregation assays were performed in a cone-plate viscometer, which consists of a stationary plate placed beneath a rotating cone (1° angle) maintained at 37°C (RotoVisco 1; Haake, Newington, NH). Mixed suspensions of PMNs and WM9 cells, respectively prelabeled with LDS-751 (red) and tetramethylrhodamine isothiocyanate (TRITC; orange), were placed on the plate at the concentration ratio of 1:1 (106 cells/ml, 500 µl each cell type) and were allowed to equilibrate for 1 min. Thereafter, the heterotypic cell suspensions were stimulated with 1 µM fMLP for 2 min before the application of shear. Exposure of cell suspensions to a linear velocity gradient resulted in collisions between the faster moving cells near the rotating cone and the slower moving cells near the stationary plate (12). Shear rate, G, was varied from 62.5 to 800 s–1 (typically for the microcirculation) (46) for preset shear duration, t, ranging from 30 to 300 s. To understand the dependence of PMN-melanoma aggregation on shear rate and shear stress, different effects of shear stress (
) and shear rate (G) were separated by using dextran (MW 2 x 106, Sigma) to vary the media viscosity,
, so that shear stress (
=
G) can be held constant while shear rate changes, or vice versa. After shear, aliquots were immediately fixed with 1% formaldehyde at room temperature and were subsequently analyzed with the Guava Personal Cytometer (Guava Technologies, Burlingame, CA). The size distribution and cellular composition of aggregates generated in the cone-plate viscometer were determined by a two-color flow cytometric methodology that was published (28), in which PMNs and WM9 cells were labeled with different fluorescence dyes so that the PMNs and WM9 population could be isolated by gating on their characteristic forward versus side scatter. The heterotypic aggregation was quantified by analyzing the dot plot between the red (due to LDS-751) and the orange (due to TRITC) fluorescence channels (Fig. 1A). Heterotypic aggregation was quantified as the percentage of bound WM9 cells to PMNs in total WM9 cells:
![]() | (1) |
|
/G
0.043
0.003 s under the experimental shear rate G) (1, 26, 34). We have previously shown that two cells are most likely linked by only one bond initially (24), such that Pa
Acmrmlkf <t>. Here Ac is the contact area of the two cells; mr and ml are the respective site densities of receptor and ligand; kf is the forward rate of the receptor-ligand pair; and Acmrmlkf is the effective forward rate. For heterotypic aggregation in a Couette flow, the total collision frequency per unit volume Hc is determined by the cell concentrations C1 (e.g., melanoma cells) and C2 (e.g., PMNs), the shear rate G, and the cell radii r1 and r2; specifically, Hc = 4(r1 + r2)3 GC1C2/3 (38). Thus, the probability of doublets formed per unit time per melanoma cell, Pp, follows Pp = HcPa/C1 = 1.15
(r1 + r2)3 C2Acmrmlkf. Once a doublet forms, more bonds may form or the existing bonds may break in the remaining shear duration. This bond evolution is modeled here by using the equations of a previously developed probabilistic model (24):
![]() | (2) |
In our previous model (24), the effective forward rate Acmrmlkf was assumed to be constant over simulation for all receptor-ligand pairs cross-linking the doublets. However, several reports from the cone-plate shear experiments indicated that the avidity decreased after cytokine stimulation even though the expressions of β2-integrin on PMNs and ICAM-1 on WM9 cells were upregulated (29, 43). To account for this decrease, an exponential-decay model for the effective forward rate was proposed in the present simulation:
![]() | (3) |
, which was previously introduced by Neelamegham et al. (29) in a deterministic model for homotypic neutrophil aggregations, describes the time-dependent changes in cell adhesiveness. Numerical calculation strategies. Shear-induced formation and breakage of PMN and WM9 heterotypic doublets were predicted by using the above model. Since the most aggregates were found to be PMN-WM9 heterotypic doublets (>90%) ( Fig. 1A), it is reasonable to neglect the effects of multiplets (>2) when predicting the aggregation kinetics. In a Couette flow to be considered here, the formation of new doublets mediated by one bond and the evolution of formed bonds in existing doublets were coupled to determine the percentage of doublets at time t. To track this percentage, the initial value of aggregation percentage at t = 0 was assumed to be zero, the newly formed doublets were added into a doublet pool, and the multiple singlet dissociated from existing doublets was pooled into a singlet subgroup at an arbitrary time t (t > 0).
In the current numerical calculations, two strategies were taken to fit the data with the model. One was global fitting, in which different data sets at different shear rates and medium viscosities were pooled together and a single set of four parameters [kr0, a, (Acmrmlkf)0, and
] was used (cf.
Table 2). The other was individual fitting, in which an individual set of three parameters [kr0, (Acmrmlkf)0, and
] was used at each shear rate and medium viscosity, together with an estimated interaction range, a, from global fitting (cf. Table 2). In individual fitting, it is hard to adjust independently the kinetic parameters (kr0 and a) from the Bell model. This is different from global fitting, which lumps the data with at least two shear rates and can predict two parameters respectively. Thus, global fitting was not performed for the three cases of aggregation between fMLP-stimulated PMNs and TNF-
-stimulated WM9 cells, since it is unknown whether stimulating WM9 cells with various TNF-
concentrations induces conformational changes in ICAM-1, which could vary the 2D kinetics of β2-integrin-ICAM-1 interactions.
|
|
The best fit of the above numerical calculation was obtained by adjusting a set of kinetic parameters [kr0, a, (Acmrmlkf)0, and
] (four-parameter prediction for global fitting) or [kr0, (Acmrmlkf)0, and
] (three-parameter prediction for individual fitting) that minimized the error (
2) between the data and the predictions (31). The
2 statistic, or weighted sum of square of errors, was defined by
![]() |
i are the measurement, prediction, and standard deviation at xi, respectively, and N is the number of data points. Since the standard deviations of measured aggregation percentages were significantly different with different shear durations for an individual aggregation percentage and the smallest deviation contributes to the largest
2 statistic, the average standard deviation
![]() |
2 statistic,
2v2, where
is the number of degrees of freedom (= N – Nf, where Nf is the number of fitting parameters), can be used to measure both the appropriateness of the proposed model and the quality of the data. The statistical significance of the difference between the 2D kinetic rates and the binding affinities of the β2-integrin-ICAM-1 pairs in different shear rates and medium viscosities with different chemotactic simulations was assessed using Student's t-test. | RESULTS |
|---|
|
|
|---|
= 1.0 cP). In addition, more WM9 cells were found to form aggregations with PMNs at a low shear rate, 62.5 s–1, whereas high shear rates (400–800 s–1) significantly decreased the aggregations between WM9 cells and PMNs (Fig. 1B). Shear rates affect aggregation of PMNs and WM9 cells. Our recent studies using a flow chamber assay have reported that PMN-facilitated melanoma adhesion to the EC could be a two-step process, which is shear-rate dependent (18). However, it is not clear how aggregations between PMNs and melanoma cells are affected by the shear rates. Current experimental results indicated that the aggregation percentage remained nearly the same when the shear stress varied from 0.625, 1.25, to 2 dyn/cm2 at a fixed shear rate G = 62.5 s–1 (Fig. 2A) and from 2, 4, to 6.4 dyn/cm2 at G = 200 s–1 (Fig. 2B). In contrast, the aggregation percentage inversely increased when G was reduced from 200 to 62.5 s–1 under a fixed shear stress of 2 dyn/cm2 (Fig. 2C) and from 400 to 200 s–1 under 4 dyn/cm2 (Fig. 2D), suggesting that the shear-induced aggregation of fMLP-stimulated PMNs and WM9 cells is shear-rate dependent.
|
To test whether β2-integrin-ICAM-1 interactions affect the heterotypic aggregation, PMNs and WM9 cells were treated with fMLP and TNF-
, respectively, and the PMN-WM9 aggregations were measured. Results indicated that after fMLP stimulation, the Mac-1 expression on PMNs increased significantly (Fig. 3A). ICAM-1 expressions on TNF-
-stimulated WM9 cells were also upregulated at TNF-
concentrations of 10 and 100 U/ml, whereas there were no differences in ICAM-1 expressions for unstimulated and stimulated WM9 cells at low concentration of 1 U/ml (Fig. 3A). In addition, time-dependent expressions of LFA-1 and Mac-1 on PMNs as well as of ICAM-1 on WM9 cells were also investigated under a shear condition. Results showed that there was no difference in LFA-1 expression between nonstimulated and fMLP-stimulated PMNs even though expression of LFA-1 increased over time for both nonstimulated and fMLP-stimulated cases (Fig. 3B). In contrast, Mac-1 expression on fMLP-stimulated PMNs was significantly higher than that on nonstimulated PMNs. Mac-1 expression on fMLP-stimulated PMNs increased over time, whereas its expression on nonstimulated PMNs did not change very much (Fig. 3C). The ICAM-1 expression on WM9 cells increased significantly after TNF-
stimulation. However, it did not change in the entire shear duration (Fig. 3D).
|
(e.g., at 10 and 100 U/ml) significantly increased the WM9-PMN heterotypic aggregations compared with control cases without TNF-
stimulation (Fig. 4B). Functional blocking of β2-integrin on PMNs or ICAM-1 on WM9 cells almost demolished the heterotypic aggregation of PMNs and WM9 cells (Fig. 4C), suggesting that the specific binding between β2-integrin on PMNs and ICAM-1 on WM9 cells is critical for the formation of PMN-WM9 aggregations.
|
2) are listed in Table 2, with best fit depending mainly on the standard deviation of the measured data. The highest
2 value (115.14) was due to less best-fitting to those two cases at a high shear rate (200 s–1) with both medium viscosities of
= 2.0 and 3.2 cP (data not shown), which is still reasonable when four parameters were used to best-fit total 45 data points in global fitting.
|
were estimated by averaging the parameters calculated by best-fitting the data for each individual case. Zero-force reverse rate, kr0, for fMLP-stimulated PMNs was similar to that for unstimulated PMNs (0.57 ± 0.08 and 0.33 ± 0.10 s–1, respectively; P > 0.1). Effective forward rate, (Acmrmlkf)0, although being 2.1-fold higher for fMLP-stimulated PMNs, was not significantly different from that for unstimulated PMNs (3.39 ± 0.56 and 1.60 ± 0.46 s–1, respectively; P > 0.1) when they respectively interacted with unstimulated WM9 cells. Decay factor
appeared to be insensitive to stimulation for PMNs [(1.29 ± 0.22) and (0.61 ± 0.16) x10–3 s–1 for fMLP-stimulated and -unstimulated PMNs, respectively; P > 0.1]. These kinetic parameters and decay factor for fMLP-stimulated PMNs were similar to those when fMLP-stimulated PMNs interacted with TNF-
-stimulated WM9 cells at 1 U/ml [kr0= 0.60, (Acmrmlkf)0 = 3.52, and
= 1.84 x 10–3 s–1], suggesting that stimulating WM9 cells with low TNF-
concentration has no significant impact on 2D kinetics of β2-integrin-ICAM-1 interactions. At 10 and 100 U/ml TNF-
concentrations, however, zero-force reverse rates (0.93 and 1.97 s–1, respectively) were 1.6- and 3.3-fold higher, and effective forward rates (6.16 and 14.52 s–1, respectively) were 1.8- and 4.1-fold higher than those at 1 U/ml, whereas the decay factors (0.43 and 0.14 s–1, respectively) were much smaller than that at 1 U/ml. Moreover, the mean values of two kinetic parameters and decay factor obtained from individual fitting were in excellent agreements with those obtained from global fitting (Table 2). The interaction range, a, obtained from global fitting (0.41 and 0.53 x10–10 m for fMLP-stimulated and -unstimulated PMNs, respectively) was similar to that previously obtained for
4β7-integrin (0.41x10–10 m) (8). Blockage of β2-integrin and ICAM-1, respectively, reduced zero-force reverse rate and effective binding affinity significantly, but not interaction range (Table 2), imparting the confidence that nonspecific interactions between other surface adhesive molecular pairs induced a low-level baseline PMN-WM9 aggregation. Taken together, these results of 2D kinetics for β2-integrin-ICAM-1 binding were consistent with experimental observations in aggregation kinetics of PMN-WM9 interactions, providing quantitative understanding of melanoma cell aggregations to PMNs under shear conditions, as well as further validation to the model.
Numerical analysis on kinetics parameters.
Further analyses of the kinetic parameters and decay factor were performed with the numerical calculations for aggregation of fMLP-stimulated PMNs and unstimulated WM9 cells at G = 100 s–1 and
= 1.0 cP. To isolate the dependence of the aggregation kinetics on individual parameters, one parameter was varied in each calculation. As shown in Fig. 6, the maximum aggregation percentage shifted upward to the right when the zero-force reverse rate was lowered, suggesting that the lower reverse rate enhances the total aggregation and prolonged the ascending phase (Fig. 6A). In contrast, it shifted downward to the left when the effective forward rate at t = 0 was lowered, implying that the lower forward rate decreases the total aggregation and shortened the ascending phase (Fig. 6B). The aggregation percentage shifted upward to the right when the interaction range (Fig. 6C) or the decay factor was decreased (Fig. 6D). These results show that the kinetic parameters kr0, a, and (Acmrmlkf)0 and decay factor
specifically regulate the PMN-WM9 aggregation kinetics.
|
| DISCUSSION |
|---|
|
|
|---|
PMN-facilitated melanoma adhesion to and subsequent migration through the EC appears to be a "two-step" process that involves initial PMN tethering on the EC and subsequently melanoma cells being captured by tethered PMNs (18). This process could be a result of regulation of IL-8 expression in melanoma-stimulated PMN inflammatory response and activation (30). PMN tethering has been found to be both shear-rate and shear-stress dependent, although melanoma cell adhesion to the EC via tethered PMNs has been shown to be shear-rate dependent only (18, 37). However, little is known regarding the mechanisms involved. In the present study, using a cone-plate viscometer to generate a uniform shear field, aggregations between melanoma cells and PMNs have been characterized and quantified to investigate the mechanism of the shear-rate-dependent melanoma adhesion to the EC mediated by PMNs. Our results have indicated that hydrodynamic shear regulates PMN-WM9 heterotypic aggregation that is dependent on shear rates rather than shear stresses. The heterotypic aggregation appears to peak after
60 s under the shear and starts to decrease afterward. Early stage of fluid shear may increase PMN-WM9 cell interactions modulated by cell-cell collisions; however, the accumulated tensile forces may overweigh the strength of cell-cell adhesive bonds and break up the aggregations after a longer exposure to the shear. Relative velocities of cells in a fluid field are determined by the shear rate that modulates the collision frequency and contact time between cells. A lower shear rate increases the time that cells are in contact, thus having higher probability of formation for WM9-PMN aggregations. On the other hand, shear stress dictates the forces applied to cells individually and the intermolecular bonds between the cells. The shear-rate dependence of melanoma cells and PMNs aggregation found from this aggregation study elucidates a possible mechanism that explains why melanoma cell adhesion to the EC facilitated by PMNs under flow conditions is influenced by the hydrodynamic shear rates.
Similar findings in shear-rate-dependent bond formation has been reported when individual PSGL-1-expressing PMNs roll over and tether to a P-selectin-immobilized substrate (5), suggesting that P-selectin and PSGL-1 bond formation could also be a function of shear rate, hence the kinetics of receptor and ligand association. In contrast, the kinetics of bond dissociation is a function of shear stress, therefore the force on the bonds (5). Other studies have shown that LFA-1, Mac-1, and L-selectin on PMNs are requisite for the heterotypic aggregation with colon carcinoma-expressing ICAM-1, sialylated molecules, and CD44 (11, 15, 16). Expression of variant isoforms of CD44 on melanoma cells also has been reported (32), which may potentially mediate interactions of PMNs and melanoma cells through L-selectin on PMNs and CD44 on melanoma cells. In the present study, however, we have shown that blocking either ICAM-1 on WM9 cells or β2-integrins on PMNs almost abolished heterotypic WM9-PMN aggregation, indicating ICAM-1 bindings to β2-integrins may play more influential roles than other receptors in mediating the WM9-PMN aggregation in a shear flow. fMLP was used to regulate the β2-integrin expressions on PMNs, which allowed us to investigate the effects of PMN activation on heterotypic aggregation of PMN and melanoma cells. Results have clearly indicated that the existence of inflammatory stimulus could boost the PMN-melanoma cell aggregation under shear conditions. We have found LFA-1 expression on PMNs remains to be about the same after fMLP stimulation, which is comparable to LFA-1 expression on resting PMNs (3). In contrast, fMLP stimulation results in an increase in Mac-1 expression that can reach a plateau within 2–4 min (3, 14). An increased expression in Mac-1 may contribute to a higher extent of melanoma cells binding to fMLP-stimulated PMNs than that to unstimulated PMNs in response to shear exposure in short times (e.g., up to 120 s). However, after a long exposure to the shear, there are no significant differences in WM9-PMN aggregation between fMLP-stimulated and unstimulated cases. The possible explanation is that the increase in aggregation is rather transient because previous studies have also shown increased CD11b/CD18 avidity could be reversed over minutes unless increasing stimulus would be further applied (14, 22). In addition, a recent study has reported that CD18 expression could be downregulated on long exposure to fluid shear (10). Therefore, the differences in CD18 expression from fMLP-stimulated and unstimulated PMNs may diminish after a longer exposure to the shear.
There is now evidence that inflammatory cytokines and chemokines, which can be produced by the tumor cells and/or tumor-associated leucocytes and platelets, may contribute directly to malignant progression (7, 21). For example, previous studies have shown that interactions of PMN and melanoma cells can induce increased secretion of inflammatory cytokine IL-8 from a tumor microenvironment (30) and IL-8 has been shown to upregulate the expression of β2-integrins on PMNs (9, 19). This may further enhance the binding between ICAM-1 on melanoma cells and β2-integrins on PMN and thus facilitate melanoma cell adhesion to the EC via PMNs during the extravasation process in metastasis.
A probabilistic kinetic model together with Smoluchowski's two-body collision theory has been applied to describe the formation and breakage of doublets of PMNs and melanoma cells mediated by β2-integrin-ICAM-1 binding. Not only has this probabilistic model been extensively used to predict 2D kinetics of receptor-ligand bindings, but it is also able to estimate intrinsic kinetic rates and binding affinities of the interacting molecules (6, 13, 47). For example, our results indicate that zero-force reverse rate agrees well with those published previously (8, 23, 50). Although two types of β2-integrin receptors are involved in PMN-WM9 aggregation, and a concurrent binding model of multiple molecular species in cell adhesion has been developed by Zhu and Williams (51), it appears to be rather difficult to extract two set of the kinetics parameters from the current data sets (6 parameters to fit 5 data points per curve in individual fitting). Kinetic parameters appearing in the current model are physiologically correlated to the aggregation dynamics of WM9-PMN interactions. Forward or reverse rate determines, respectively, how fast a β2-integrin-ICAM-1 bond forms or dissociates (also how fast a WM9-PMN doublet aggregates or disaggregates). The effective binding affinity, (AcmrmlKa)0 [= (Acmrmlkf)0/kr0], governs how likely the bond remains bound in an equilibrium state. With a higher TNF-
concentration (10 or 100 U/ml), for example, a higher reverse rate of β2-integrin-ICAM-1 interaction suggests that the aggregations between TNF-
-stimulated WM9 cells and fMLP-stimulated PMNs are not as stable as that for unstimulated WM9 cells with either fMLP-stimulated or -unstimulated PMNs, whereas a higher forward rate implies that stimulated WM9 cells are more likely to form aggregations than that for unstimulated WM9 cells with PMNs (stimulated or unstimulated). A similar effective binding affinity (4.79
7.37) shows that TNF-
stimulation would not affect the equilibrium binding between WM9 and PMN cells. The interaction range, a (i.e., an estimate of mechanical bond strength), is not sensitive to chemotactic regulations, as reported in the literature for selectin-ligand and other adhesion molecules (8). The present findings provide a clue for screening the potential therapeutic targets in preventing PMN-tumor cell adhesions and subsequent metastasis.
We have also proposed an exponentially decay- and time-dependent effective forward rate Acmrmlkf (Eq. 3) in the present study to predict the biphasic time-dependent course of PMN-WM9 aggregations. Similar biphasic time dependence was previously found in PMN homotypic aggregation mediated by the transition from L-selectin- to β2-integrin-dependent adhesion (43), and an exponentially decay in time of adhesion efficiency was also proposed (29). Estimated values of decay factor
for PMN-WM9 interaction in the current study (0.14
2.0 x 10–3 s–1) are similar to those for aggregations between PMNs and ICAM-1-transfected cells (3
11 x 10–3 s–1) (28), but lower than those for PMN homotypic aggregations (13
31 x 10–3 s–1) (29). Decay factor
is assumed to be governed by the contact area (Ac), receptor., and/or ligand expression (mr, ml), and even the molecular conformation changes. The contact area between two adjacent fMLP-stimulated PMNs at 180 s was reduced by
70% compared with that at 30 s (29). β2-Integrin could move to the uropod after PMNs being stimulated by fMLP, which reduces the number of interacting molecules within the contact area (14). Although the expression of β2-integrin on PMNs is upregulated, the rapid activation of LFA-1 is transient and reversible within
30 s, whereas the active conformation of Mac-1 is stable beyond 10 min during shear (36). The effective forward rates (Ackf)0 at t = 0 from (Acmrmlkf)0 for the PMN-WM9 aggregations were found to be 0.014 (between fMLP-stimulated PMNs and unstimulated WM9 cells), 0.010 (between unstimulated PMNs and unstimulated WM9 cells), 0.013, 0.013, and 0.024 (between fMLP-stimulated PMNs and stimulated WM9 cells by TNF-
at 1, 10, and 100 U/ml, respectively), indicating that the increasing effective forward rate is mostly caused by the increasing expression of adhesion molecules.
Finally, the time course of aggregation percentage between PMNs and WM9 melanoma cells exhibits a biphasic transition and shear-rate dependence. A modified probabilistic kinetic model presented in the current study reproduces the data well and enables us to quantify the kinetic rates and affinities of interacting β2-integrin and ICAM-1 bindings between PMNs and tumor cells. These findings provide a rationale and mechanistic basis for understanding leukocyte-tumor cell interactions mediated by specific receptor-ligand interactions under flow conditions, which provides insights into potential targets in inhibiting PMN-mediated melanoma extravasation and subsequent metastasis development.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
* S. Liang and C. Fu contributed equally to this work. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. The integrin Vla-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 128: 1243–1253, 1995.
3. Bateman J, Parida SK, Nash GB. Neutrophil integrin assay for clinical studies. Cell Biochem Funct 11: 87–91, 1993.[CrossRef][Web of Science][Medline]
4. Bell GI. Models for the specific adhesion of cells to cells. Science 200: 618–627, 1978.
5. Chen SQ, Springer TA. Selectin receptor-ligand bonds: Formation limited by shear rate and dissociation governed by the Bell model. Proc Natl Acad Sci USA 98: 950–955, 2001.
6. Chesla SE, Selvaraj P, Zhu C. Measuring two-dimensional receptor-ligand binding kinetics by micropipette. Biophys J 75: 1553–1572, 1998.[Web of Science][Medline]
7. Coussens LM, Werb Z. Inflammation and cancer. Nature 420: 860–867, 2002.[CrossRef][Medline]
8. De Chateau M, Chen SQ, Salas A, Springer TA. Kinetic and mechanical basis of rolling through an integrin and novel Ca2+-dependent rolling and Mg2+-dependent firm adhesion modalities for the alpha 4 beta 7-MAdCAM-1 interaction. Biochemistry 40: 13972–13979, 2001.[CrossRef][Web of Science][Medline]
9. Diamond MS, Springer TA. The dynamic regulation of integrin adhesiveness. Curr Biol 4: 506–517, 1994.[CrossRef][Web of Science][Medline]
10. Fukuda S, Schmid-Schonbein GW. Regulation of CD18 expression on neutrophils in response to fluid shear stress. Proc Natl Acad Sci USA 100: 13152–13157, 2003.
11. Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos K. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. FASEB J 19: 337–339, 2005.[Web of Science]
12. Hentzen ER, Neelamegham S, Kansas GS, Benanti JA, McIntire LV, Smith CW, Simon SI. Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule-1. Blood 95: 911–920, 2000.
13. Huang J, Chen J, Chesla SE, Yago T, Mehta P, Mcever RP, Zhu C, Long M. Quantifying the effects of molecular orientation and length on two-dimensional receptor-ligand binding kinetics. J Biol Chem 279: 44915–44923, 2004.
14. Hughes BJ, Hollers JC, Crocketttorabi E, Smith CW. Recruitment of Cd11B/Cd18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest 90: 1687–1696, 1992.[Web of Science][Medline]
15. Jadhav S, Bochner BS, Konstantopoulos K. Hydrodynamic shear regulates the kinetics and receptor specificity of polymorphonuclear leukocyte-colon carcinoma cell adhesive interactions. J Immunol 167: 5986–5993, 2001.
16. Jadhav S, Konstantopoulos K. Fluid shear- and time-dependent modulation of molecular interactions between PMNs and colon carcinomas. Am J Physiol Cell Physiol 283: C1133–C1143, 2002.
17. Kwong D, Tees DFJ, Goldsmith HL. Kinetics and locus of failure of receptor-ligand-mediated adhesion between latex spheres. 2. Protein-protein bond. Biophys J 71: 1115–1122, 1996.[Web of Science][Medline]
18. Liang S, Slattery MJ, Dong C. Shear stress and shear rate differentially affect the multi-step process of leukocyte-facilitated melanoma adhesion. Exp Cell Res 310: 282–292, 2005.[CrossRef][Web of Science][Medline]
19. Liang SL, Sharma A, Peng HH, Robertson G, Dong C. Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation. Cancer Res 67: 5814–5820, 2007.
20. Lichtenstein A. Stimulation of the respiratory burst of murine peritoneal inflammatory neutrophils by conjugation with tumor cells. Cancer Res 47: 2211–2217, 1987.
21. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 411: 375–379, 2001.[CrossRef][Medline]
22. Lo SK, Detmers PA, Levin SM, Wright SD. Transient adhesion of neutrophils to endothelium. J Exp Med 169: 1779–1793, 1989.
23. Lomakina EB, Waugh RE. Micromechanical tests of adhesion dynamics between neutrophils and immobilized ICAM-1. Biophys J 86: 1223–1233, 2004.[Web of Science][Medline]
24. Long M, Goldsmith HL, Tees DFJ, Zhu C. Probabilistic modeling of shear-induced formation and breakage of doublets cross-linked by receptor-ligand bonds. Biophys J 76: 1112–1128, 1999.[Web of Science][Medline]
25. Lum AFH, Green CE, Lee GR, Staunton DE, Simon SI. Dynamic regulation of LFA-1 activation and neutrophil arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow. J Biol Chem 277: 20660–20670, 2002.
26. McDonough DB, McIntosh FA, Spanos C, Neelamegham S, Goldsmith HL, Simon SI. Cooperativity between selectins and beta(2)-integrins define neutrophil capture and stable adhesion in shear flow. Ann Biomed Eng 32: 1179–1192, 2004.[CrossRef][Web of Science][Medline]
27. Miele ME, Bennett CF, Miller BE, Welch DR. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, Cd54) antisense oligonucleotides. Exp Cell Res 214: 231–241, 1994.[CrossRef][Web of Science][Medline]
28. Neelamegham S, Taylor AD, Burns AR, Smith CW, Simon SI. Hydrodynamic shear shows distinct roles for LFA-1 and Mac-1 in neutrophil adhesion to intercellular adhesion molecule-1. Blood 92: 1626–1638, 1998.
29. Neelamegham S, Taylor AD, Hellums JD, Dembo M, Smith CW, Simon SI. Modeling the reversible kinetics of neutrophil aggregation under hydrodynamic shear. Biophys J 72: 1527–1540, 1997.[Web of Science][Medline]
30. Peng HH, Liang S, Henderson AJ, Dong C. Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response. Exp Cell Res 313: 551–559, 2007.[CrossRef][Web of Science][Medline]
31. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical Recipes in Fortran 77: The Art of Scientific Computing. Cambridge, UK: Cambridge Univ. Press, 1992, p. 675–683.
32. Seiter S, Schadendorf D, Herrmann K, Schneider M, Rosel M, Arch R, Tilgen W, Zoller M. Expression of CD44 variant isoforms in malignant melanoma. Clin Cancer Res 2: 447–456, 1996.[Abstract]
33. Seo SM, McIntire LV, Smith CW. Effects of IL-8, Gro-
, and LTB4 on the adhesive kinetics of LFA-1 and Mac-1 on human neutrophils. Am J Physiol Cell Physiol 281: C1568–C1578, 2001.
34. Shankaran H, Neelamegham S. Hydrodynamic forces applied on intercellular bonds, soluble molecules, and cell-surface receptors. Biophys J 86: 576–588, 2004.[Web of Science][Medline]
35. Shevde LA, Welch DR. Metastasis suppressor pathways - an evolving paradigm. Cancer Lett 198: 1–20, 2003.[CrossRef][Web of Science][Medline]
36. Simon SI, Green CE. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng 7: 151–185, 2005.[CrossRef][Web of Science][Medline]
37. Slattery MJ, Liang S, Dong C. Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation. Am J Physiol Cell Physiol 288: C831–C839, 2005.
38. Smoluchowski MV. Versuch einer mathematischen Theorie der Koagulationskinetik kolloider Losungen. Z Phys Chem 92: 129–168, 1917. [in German]
39. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 22: 3138–3151, 2003.[CrossRef][Web of Science][Medline]
40. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration - the multistep paradigm. Cell 76: 301–314, 1994.[CrossRef][Web of Science][Medline]
41. Tandon P, Diamond SL. Hydrodynamic effects and receptor interactions of platelets and their aggregates in linear shear flow. Biophys J 73: 2819–2835, 1997.[Web of Science][Medline]
42. Tandon P, Diamond SL. Kinetics of beta(2)-integrin and L-selectin bonding during neutrophil aggregation in shear flow. Biophys J 75: 3163–3178, 1998.[Web of Science][Medline]
43. Taylor AD, Neelamegham S, Hellums JD, Smith CW, Simon SI. Molecular dynamics of the transition from L-selectin- to beta(2)-integrin-dependent neutrophil adhesion under defined hydrodynamic shear. Biophys J 71: 3488–3500, 1996.[Web of Science][Medline]
44. Tees DFJ, Coenen O, Goldsmith HL. Interaction forces between red-cells agglutinated by antibody. 4. Time and force dependence of break-up. Biophys J 65: 1318–1334, 1993.[Web of Science][Medline]
45. Tees DFJ, Goldsmith HL. Kinetics and locus of failure of receptor-ligand-mediated adhesion between latex spheres. 1. Protein-carbohydrate bond. Biophys J 71: 1102–1114, 1996.[Web of Science][Medline]
46. Turitto VT. Blood viscosity, mass transport, thrombogenesis. Prog Hemost Thromb 6: 139–177, 1982.[Web of Science][Medline]
47. Wu L, Xiao B, Jia X, Zhang Y, Lu S, Chen J, Long M. Impact of carrier stiffness and microtopology on two-dimensional kinetics of P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) interactions. J Biol Chem 282: 9846–9854, 2007.
48. Wu QD, Wang JH, Condron C, Bouchier-Hayes D, Redmond HP. Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol 280: C814–C822, 2001.
49. Zetter BR. Adhesion molecules in tumor-metastasis. Semin Cancer Biol 4: 219–229, 1993.[Web of Science][Medline]
50. Zhang F, Marcus WD, Goyal NH, Selvaraj P, Springer TA, Zhu C. Two-dimensional kinetics regulation of alpha(L)beta(2)-ICAM-1 interaction by conformational changes of the alpha(L)-inserted domain. J Biol Chem 280: 42207–42218, 2005.
51. Zhu C, Williams TE. Modeling concurrent binding of multiple molecular species in cell adhesion. Biophys J 79: 1850–1857, 2000.[Web of Science][Medline]
This article has been cited by other articles:
![]() |
S. Liang and C. Dong Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions Am J Physiol Cell Physiol, September 1, 2008; 295(3): C701 - C707. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |